Smoking is more dangerous for a person with MS than it is for the average person. Of course, smoking is bad for everyone, and quitting is the single healthiest thing a smoker can do, but that’s even truer for people with MS.
A number of important studies show smoking increases the likelihood of developing MS and of the disease progressing.
What do studies say about the relationship between smoking & MS?
- The Nurses’ Health Study in 2001 found the risk of getting MS was 1.6 times greater for current smokers, and 1.2 times greater for past smokers than for women who had never smoked. The longer a woman had smoked, the greater her risk of MS; it was highest (1.7 times greater) for those who had smoked for more than 25 years.
- A Norwegian study in 2003 found smokers were 1.8 times likelier to develop MS than non-smokers were.
- A 2005 Harvard study found that people with MS who had ever smoked were 3 to 4 times likelier to develop secondary progressive MS than those who had never smoked.
- A Swedish study in 2008 confirmed in a group of 122 people with MS that smokers were much more likely to have progressive disease, and to progress at an earlier age.
- Second-hand smoke is harmful in MS: A French study showed in 2007 that children were more than twice as likely to get MS if their parents smoked. The longer their exposure, the more likely MS was to develop
- A 2008 Austrian study showed that for people who’d had an initial attack suggestive of MS, smokers were nearly twice as likely to develop MS, and to do so earlier than non-smokers
- A 2009 Johns Hopkins report noted that subjects who had started smoking before the age of 17 were much more likely to develop MS.
- Overcoming MS’s HOLISM study showed that people with MS who smoke not only had a lower quality of life but also a startling 90% increase in the likelihood of major mobility impairments
Despite all this evidence, studies have shown that people with MS smoke more than the general population
For people with MS who still smoke, giving up smoking is likely to positively affect the course of MS. This reasonably simple change can make a big difference in how the disease progresses and to quality of life.